$7.44
0.40% yesterday
Nasdaq, Aug 26, 10:01 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Stock price

$7.44
+1.69 29.39% 1M
-2.26 23.30% 6M
+0.00 0.00% YTD
+1.16 18.47% 1Y
-13.11 63.80% 3Y
-18.09 70.86% 5Y
-18.09 70.86% 10Y
-18.09 70.86% 20Y
Nasdaq, Closing price Tue, Aug 26 2025
-0.03 0.40%

Key metrics

Basic
Market capitalization
$470.0m
Enterprise Value
$455.3m
Net debt
positive
Cash
$69.3m
Shares outstanding
63.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.2 | 2.0
EV/Sales
2.1 | 2.0
EV/FCF
negative
P/B
4.8
Financial Health
Equity Ratio
52.0%
Return on Equity
-49.4%
ROCE
-29.1%
ROIC
-
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$213.8m | $231.6m
EBITDA
$-38.5m | $624.2k
EBIT
$-47.9m | $-49.2m
Net Income
$-49.2m | $-51.6m
Free Cash Flow
$-29.2m
Growth (TTM | estimate)
Revenue
7.7% | 10.6%
EBITDA
33.2% | 101.3%
EBIT
26.3% | 11.6%
Net Income
22.8% | 7.5%
Free Cash Flow
29.8%
Margin (TTM | estimate)
Gross
80.1%
EBITDA
-18.0% | 0.3%
EBIT
-22.4%
Net
-23.0% | -22.3%
Free Cash Flow
-13.6%
More
EPS
$-0.8
FCF per Share
$-0.5
Short interest
5.8%
Employees
477
Rev per Employee
$440.0k
Show more

Is Treace Medical Concepts Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Treace Medical Concepts Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Treace Medical Concepts Inc forecast:

7x Buy
58%
5x Hold
42%

Analyst Opinions

12 Analysts have issued a Treace Medical Concepts Inc forecast:

Buy
58%
Hold
42%

Financial data from Treace Medical Concepts Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
214 214
8% 8%
100%
- Direct Costs 43 43
11% 11%
20%
171 171
7% 7%
80%
- Selling and Administrative Expenses 198 198
4% 4%
93%
- Research and Development Expense 21 21
12% 12%
10%
-38 -38
33% 33%
-18%
- Depreciation and Amortization 9.43 9.43
28% 28%
4%
EBIT (Operating Income) EBIT -48 -48
26% 26%
-22%
Net Profit -49 -49
23% 23%
-23%

In millions USD.

Don't miss a Thing! We will send you all news about Treace Medical Concepts Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Treace Medical Concepts Inc Stock News

Neutral
Seeking Alpha
19 days ago
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants John T. Treace - Founder, Chairman & CEO Mark L.
Neutral
The Motley Fool
19 days ago
Treace Medical (TMCI) Q2 Revenue Up 7%
Neutral
GlobeNewsWire
20 days ago
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the second quarter ended June 30, 2025.
More Treace Medical Concepts Inc News

Company Profile

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Head office United States
CEO John Treace
Employees 477
Founded 2013
Website www.treace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today